Prolymphocytic leukemia: postmortem findings after long-term survival.
A patient had prolymphocytic leukemia and survived for 44 months. A partial remission for more than 11 months and a short complete remission were induced by agents commonly used for the treatment of acute myelocytic leukemia. However, surface markers identified the disease as of B-cell origin.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001402:B-Lymphocytes; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D013156:Splenectomy; D013163:Splenomegaly / Q000209:etiology; D013997:Time Factors
D000970:Antineoplastic Agents